Article
Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability.
Journal of medicinal chemistry - 4 Oct 2007
Cullen Matthew D, Deng Bo-Liang, Hartman Tracy L, Watson Karen M, Buckheit Robert W, Pannecouque Christophe, Clercq Erik De, Cushman Mark
Abstract excerpt
Non-nucleoside inhibitors of HIV reverse transcriptase (NNRTIs), albeit not the mainstays of HIV/AIDS treatment, have become increasingly important in highly active antiretroviral therapy (HAART) due to their unique mechanism of action. Several years ago our group identified the alkenyldiarylmethanes (ADAMs) as a potent and novel class of NNRTIs; however, the most active compounds were found to be metabolically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
